These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
419 related articles for article (PubMed ID: 18029909)
21. The cholesterol-raising factor from coffee beans, cafestol, as an agonist ligand for the farnesoid and pregnane X receptors. Ricketts ML; Boekschoten MV; Kreeft AJ; Hooiveld GJ; Moen CJ; Müller M; Frants RR; Kasanmoentalib S; Post SM; Princen HM; Porter JG; Katan MB; Hofker MH; Moore DD Mol Endocrinol; 2007 Jul; 21(7):1603-16. PubMed ID: 17456796 [TBL] [Abstract][Full Text] [Related]
22. In vivo imaging of farnesoid X receptor activity reveals the ileum as the primary bile acid signaling tissue. Houten SM; Volle DH; Cummins CL; Mangelsdorf DJ; Auwerx J Mol Endocrinol; 2007 Jun; 21(6):1312-23. PubMed ID: 17426284 [TBL] [Abstract][Full Text] [Related]
23. Cross-talk between farnesoid-X-receptor (FXR) and peroxisome proliferator-activated receptor gamma contributes to the antifibrotic activity of FXR ligands in rodent models of liver cirrhosis. Fiorucci S; Rizzo G; Antonelli E; Renga B; Mencarelli A; Riccardi L; Morelli A; Pruzanski M; Pellicciari R J Pharmacol Exp Ther; 2005 Oct; 315(1):58-68. PubMed ID: 15980055 [TBL] [Abstract][Full Text] [Related]
24. Upregulation of decorin by FXR in vascular smooth muscle cells. He F; Zhang Q; Kuruba R; Gao X; Li J; Li Y; Gong W; Jiang Y; Xie W; Li S Biochem Biophys Res Commun; 2008 Aug; 372(4):746-51. PubMed ID: 18514055 [TBL] [Abstract][Full Text] [Related]
25. Farnesoid X receptor agonist reduces serum asymmetric dimethylarginine levels through hepatic dimethylarginine dimethylaminohydrolase-1 gene regulation. Hu T; Chouinard M; Cox AL; Sipes P; Marcelo M; Ficorilli J; Li S; Gao H; Ryan TP; Michael MD; Michael LF J Biol Chem; 2006 Dec; 281(52):39831-8. PubMed ID: 17065154 [TBL] [Abstract][Full Text] [Related]
26. Cepharanthine inhibits in vitro VSMC proliferation and migration and vascular inflammatory responses mediated by RAW264.7. Paudel KR; Karki R; Kim DW Toxicol In Vitro; 2016 Aug; 34():16-25. PubMed ID: 27021874 [TBL] [Abstract][Full Text] [Related]
27. T0901317 is a dual LXR/FXR agonist. Houck KA; Borchert KM; Hepler CD; Thomas JS; Bramlett KS; Michael LF; Burris TP Mol Genet Metab; 2004; 83(1-2):184-7. PubMed ID: 15464433 [TBL] [Abstract][Full Text] [Related]
28. Activation of the farnesoid X receptor represses PCSK9 expression in human hepatocytes. Langhi C; Le May C; Kourimate S; Caron S; Staels B; Krempf M; Costet P; Cariou B FEBS Lett; 2008 Mar; 582(6):949-55. PubMed ID: 18298956 [TBL] [Abstract][Full Text] [Related]
29. The glucocorticoid mometasone furoate is a novel FXR ligand that decreases inflammatory but not metabolic gene expression. Bijsmans IT; Guercini C; Ramos Pittol JM; Omta W; Milona A; Lelieveld D; Egan DA; Pellicciari R; Gioiello A; van Mil SW Sci Rep; 2015 Sep; 5():14086. PubMed ID: 26369990 [TBL] [Abstract][Full Text] [Related]
30. Peroxisome proliferator--activated receptor gamma activators inhibit interleukin-1beta-induced nitric oxide and matrix metalloproteinase 13 production in human chondrocytes. Fahmi H; Di Battista JA; Pelletier JP; Mineau F; Ranger P; Martel-Pelletier J Arthritis Rheum; 2001 Mar; 44(3):595-607. PubMed ID: 11263774 [TBL] [Abstract][Full Text] [Related]
31. The nuclear hormone receptor farnesoid X receptor (FXR) is activated by androsterone. Wang S; Lai K; Moy FJ; Bhat A; Hartman HB; Evans MJ Endocrinology; 2006 Sep; 147(9):4025-33. PubMed ID: 16675527 [TBL] [Abstract][Full Text] [Related]
32. Differential regulation of vascular smooth muscle nuclear factor kappa-B by G alpha q-coupled and cytokine receptors. Abbott KL; Robida AM; Davis ME; Pavlath GK; Camden JM; Turner JT; Murphy TJ J Mol Cell Cardiol; 2000 Mar; 32(3):391-403. PubMed ID: 10731439 [TBL] [Abstract][Full Text] [Related]
33. FXR regulates organic solute transporters alpha and beta in the adrenal gland, kidney, and intestine. Lee H; Zhang Y; Lee FY; Nelson SF; Gonzalez FJ; Edwards PA J Lipid Res; 2006 Jan; 47(1):201-14. PubMed ID: 16251721 [TBL] [Abstract][Full Text] [Related]
34. FXR activation improves myocardial fatty acid metabolism in a rodent model of obesity-driven cardiotoxicity. Mencarelli A; Cipriani S; Renga B; D'Amore C; Palladino G; Distrutti E; Baldelli F; Fiorucci S Nutr Metab Cardiovasc Dis; 2013 Feb; 23(2):94-101. PubMed ID: 21924881 [TBL] [Abstract][Full Text] [Related]
35. Bile acid derivatives as ligands of the farnesoid X receptor. Synthesis, evaluation, and structure-activity relationship of a series of body and side chain modified analogues of chenodeoxycholic acid. Pellicciari R; Costantino G; Camaioni E; Sadeghpour BM; Entrena A; Willson TM; Fiorucci S; Clerici C; Gioiello A J Med Chem; 2004 Aug; 47(18):4559-69. PubMed ID: 15317466 [TBL] [Abstract][Full Text] [Related]
37. VPAC1 expression is regulated by FXR agonists in the human gallbladder epithelium. Chignard N; Mergey M; Barbu V; Finzi L; Tiret E; Paul A; Housset C Hepatology; 2005 Sep; 42(3):549-57. PubMed ID: 16037943 [TBL] [Abstract][Full Text] [Related]
38. The anti-inflammatory actions of LCY-2-CHO, a carbazole analogue, in vascular smooth muscle cells. Ho FM; Kang HC; Lee ST; Chao Y; Chen YC; Huang LJ; Lin WW Biochem Pharmacol; 2007 Jul; 74(2):298-308. PubMed ID: 17499220 [TBL] [Abstract][Full Text] [Related]